SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-14-003625
Filing Date
2014-05-20
Accepted
2014-05-20 13:17:05
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0314_yewbio.htm 10-Q 988626
2 CERTIFICATION f10q0314ex31i_yewbio.htm EX-31.1 9361
3 CERTIFICATION f10q0314ex31ii_yewbio.htm EX-31.2 9507
4 CERTIFICATION f10q0314ex32_yewbio.htm EX-32 5380
  Complete submission text file 0001213900-14-003625.txt   5509485

Data Files

Seq Description Document Type Size
5 yewb-20140331.xml EX-101.INS 838578
6 yewb-20140331.xsd EX-101.SCH 48713
7 yewb-20140331_cal.xml EX-101.CAL 37979
8 yewb-20140331_def.xml EX-101.DEF 65986
9 yewb-20140331_lab.xml EX-101.LAB 343891
10 yewb-20140331_pre.xml EX-101.PRE 207259
Mailing Address 294 POWERBILT AVENUE LAS VEGAS NV 89148
Business Address 294 POWERBILT AVENUE LAS VEGAS NV 89148 86-0451-82292379
Yew Bio-Pharm Group, Inc. (Filer) CIK: 0001548240 (see all company filings)

IRS No.: 261579105 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54701 | Film No.: 14857203
SIC: 0100 Agricultural Production-Crops